-
Mashup Score: 12
Elad Asher provides his take on the final results SHARE trial which suggest that P2Y12 inhibitor monotherapy after a 3-month DAPT in CAD patients undergoing PCI is non-inferior to 12-month DAPT in terms of NACE, but further research is needed in different populations… read more in this article!
Source: www.pcronline.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
RT @AsherElad: https://t.co/3yVVtfKr3E The SHARE trial #ESCCongress #ESC2023 @PCRonline @Sbrugaletta @Ortega_Paz @aayshacader @Anazmicalik…
-
-
Mashup Score: 8STOPDAPT-3: Should DAPT Remain Standard Strategy After Stent Implantation? - American College of Cardiology - 9 month(s) ago
Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to findings from the STOPDAPT-3 trial presented at ESC Congress 2023. Researchers randomized 5,966 patients with ACS or HBR from 72 centers in Japan to receive either prasugrel (3.75 mg/day) monotherapy or DAPT with aspirin (81-100 mg/day) and
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
🆕 Findings from STOPDAPT-3 show prasugrel monotherapy after #PCI w/DES was not inferior to #DAPT for major bleeding; but was non-inferior for #CVD events in patients w/ #cvACS or high bleeding risk. Read more: https://t.co/ig0Iur3mY6 #ESCCongress https://t.co/TiDhWholnX
-
-
Mashup Score: 26Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review - 9 month(s) ago
Abstract Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary disease, severe …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
A rational evidence-based approach to invasive cardiac interventions is important in patients with active, advanced cancer. Learn more in #JACCCardioOnc: https://t.co/Nc1g5KRvUe #DAPT #STEMI #epICD #CardioOnc #CardioTwitter #MedTwitter https://t.co/rbNG2QonuB
-
-
Mashup Score: 9
Background Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. This study investigated whether frailty d…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Frailty based on claims data was associated with increased risk of adverse events but no differences in effects of 30 vs. 12 months of #DAPT post-#PCI in the #DAPT Study. #AHAJournals @kfaridiMD @rwyeh @SmithBIDMC https://t.co/XNbNGwiBlv https://t.co/ZwHmvuKGso
-
-
Mashup Score: 1Modulation and personalization of therapy after acute coronary syndromes: the road to precision - 10 month(s) ago
The mortality and morbidity associated with acute coronary syndromes (ACSs) have declined markedly over the past 50 years, mainly due to the introduction of the
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
Modulation and personalization of therapy after acute coronary syndromes: the road to precision. #ACS #DAPT #LLT #SAPT #Colchicine #ImmunoModulation https://t.co/XWv4J77dKb
-
-
Mashup Score: 17Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis - 10 month(s) ago
AbstractAims. Dual-antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is the standard treatment for patients with acute coronary syndrome (AC
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
#DAPT de-escalation in acute coronary syndrome: an individual patient #MA https://t.co/ZVEL5UmjKj
-
-
Mashup Score: 8
AbstractAims. To characterize and follow patients with ST-segment elevation myocardial infarction (STEMI) at high bleeding risk (HBR) according to the predictin
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
P2Y12 inhibitor type and subsequent risk of CV events and bleeding in #STEMI patients at #HBR: a Danish 🇩🇰 all-comer registry https://t.co/MKteMIepVV @AgewallStefan @FeliceGragnano #PCI #DAPT #ESCYoung #EHJPharmacotherapy https://t.co/mnDkUs4FiM
-
-
Mashup Score: 0Modulation and personalization of therapy after acute coronary syndromes: the road to precision - 10 month(s) ago
The mortality and morbidity associated with acute coronary syndromes (ACSs) have declined markedly over the past 50 years, mainly due to the introduction of the
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Modulation and personalization of therapy after acute coronary syndromes: the road to precision | European Heart Journal. Thanks to @FrancescoPaneni for the kind invitation #EHJ #LLT #DAPT #ImmunoModulation #CCS #ACS https://t.co/2jj7hTAdE6
-
-
Mashup Score: 0Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk- A report from the SWEDEHEART registry - 11 month(s) ago
AbstractAims. Ticagrelor is associated with a lower risk of ischemic events than clopidogrel. However, it is uncertain whether the benefits of more intensive an
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Comparison between #ticagrelor and #clopidogrel in #MI : report from the SWEDEHEART. #DAPT #HBR https://t.co/6EQD8DkZw2
-
-
Mashup Score: 0ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure - 1 year(s) ago
The findings, from a small, prematurely stopped trial, need to be confirmed in larger studies, one expert says.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Researchers at #EuroPCR reported a composite of thromboembolic events, device-related thrombus, and major bleeding through 3 months was reduced w/ low-dose #DOAC vs #DAPT w/ aspirin & clopidogrel following #LAAO. @ToddNeale has the full story: https://t.co/CwkuT99i7c @TCTMD
-
Live from #ESCCongress 2023: What do you think is the future of P2Y12 inhibitor monotherapy in patients with ACS? Read this review ✍️🏼of the SHARE 📊by @AsherElad : P2Y12 inhibitor monotherapy vs #DAPT after PCI with BP-EES https://t.co/mcZJW4V1rw #CardioTwitter https://t.co/Aas6eDLf5D